- Home
- ORIC vs OLMA Comparison
ORIC vs OLMA Comparison
Compare ORIC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- OLMA
- Stock Information
- Founded
- ORIC 2014
- OLMA 2006
- Country
- ORIC United States
- OLMA United States
- Employees
- ORIC N/A
- OLMA N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- ORIC Health Care
- OLMA Health Care
- Exchange
- ORIC Nasdaq
- OLMA Nasdaq
- Market Cap
- ORIC 362.9M
- OLMA 299.7M
- IPO Year
- ORIC 2020
- OLMA 2020
- Fundamental
- Price
- ORIC $10.21
- OLMA $4.37
- Analyst Decision
- ORIC Strong Buy
- OLMA Strong Buy
- Analyst Count
- ORIC 8
- OLMA 4
- Target Price
- ORIC $18.83
- OLMA $24.50
- AVG Volume (30 Days)
- ORIC 1.2M
- OLMA 1.1M
- Earning Date
- ORIC 08-11-2025
- OLMA 08-05-2025
- Dividend Yield
- ORIC N/A
- OLMA N/A
- EPS Growth
- ORIC N/A
- OLMA N/A
- EPS
- ORIC N/A
- OLMA N/A
- Revenue
- ORIC N/A
- OLMA N/A
- Revenue This Year
- ORIC N/A
- OLMA N/A
- Revenue Next Year
- ORIC N/A
- OLMA N/A
- P/E Ratio
- ORIC N/A
- OLMA N/A
- Revenue Growth
- ORIC N/A
- OLMA N/A
- 52 Week Low
- ORIC $3.90
- OLMA $2.86
- 52 Week High
- ORIC $14.67
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- ORIC 63.99
- OLMA 48.24
- Support Level
- ORIC $10.05
- OLMA $4.45
- Resistance Level
- ORIC $10.99
- OLMA $4.73
- Average True Range (ATR)
- ORIC 0.60
- OLMA 0.31
- MACD
- ORIC -0.07
- OLMA 0.03
- Stochastic Oscillator
- ORIC 54.67
- OLMA 52.75
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.